Brief: Opyl Ltd Signs New Service Agreement With Biointelect

Pathkey.AI

25/09/2024 02:15

Sept 25 (Reuters) - Opyl Ltd  OPL.AX :
    * OPYL SIGNS NEW SERVICE AGREEMENT WITH BIOINTELECT
    * AGREEMENT TO PROVIDE ADVANCED CLINICAL TRIAL DESIGN AND
PREDICTIVE ANALYTICS THROUGH TRIALKEY PLATFORM
    * BIOINTELECT WILL ENGAGE OPYL FOR TRIAL DESIGN SERVICES AT
A FEE
OF A$5,000 PER TRIAL

Further company coverage:  OPL.AX 

 ((Reuters.Briefs@thomsonreuters.com;))